These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Decalcification can cause the failure of BRAF molecular analyses and anti-BRAFV600E VE1 immunohistochemistry. Bourhis A; Le Flahec G; Uguen A Pathol Int; 2019 Apr; 69(4):219-223. PubMed ID: 30843305 [TBL] [Abstract][Full Text] [Related]
25. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry. Yaman B; Kandiloğlu G; Akalin T Am J Dermatopathol; 2016 Feb; 38(2):113-20. PubMed ID: 26630683 [TBL] [Abstract][Full Text] [Related]
26. Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: implications on optimized targeted therapy. Saroufim M; Habib RH; Gerges R; Saab J; Loya A; Amr SS; Sheikh S; Satti M; Oberkanins C; Khalifeh I Exp Mol Pathol; 2014 Dec; 97(3):315-20. PubMed ID: 25236573 [TBL] [Abstract][Full Text] [Related]
27. Lymph node metastases of melanoma: challenges for BRAF mutation detection. Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393 [TBL] [Abstract][Full Text] [Related]
28. Distant metastasis due to heavily pigmented epithelioid melanoma with underlying BRAF V600E, NOTCH1, ERBB3, and PTEN mutations. Motaparthi K; George EV; Guo R J Cutan Pathol; 2019 Aug; 46(8):613-618. PubMed ID: 31025390 [TBL] [Abstract][Full Text] [Related]
29. Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas. Kakavand H; Crainic O; Lum T; O'Toole SA; Kefford RF; Thompson JF; Wilmott JS; Long GV; Scolyer RA Pathology; 2014 Apr; 46(3):193-8. PubMed ID: 24614711 [TBL] [Abstract][Full Text] [Related]
30. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. van Dijk MC; Bernsen MR; Ruiter DJ Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402 [TBL] [Abstract][Full Text] [Related]
31. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444 [TBL] [Abstract][Full Text] [Related]
32. BRAFV600E detection in melanoma is highly improved by COLD-PCR. Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C Clin Chim Acta; 2011 May; 412(11-12):901-5. PubMed ID: 21262211 [TBL] [Abstract][Full Text] [Related]
33. [Progress of anti-tumor study based on BRAF]. Yan GR; Xu ZJ; Wang HY; Zhu WL Yao Xue Xue Bao; 2012 Dec; 47(12):1567-74. PubMed ID: 23460959 [TBL] [Abstract][Full Text] [Related]
34. BRAF mutation screening in melanoma: is sentinel lymph node reliable? Nardin C; Puzenat E; Prétet JL; Algros MP; Doussot A; Puyraveau M; Mougin C; Aubin F Melanoma Res; 2015 Aug; 25(4):328-34. PubMed ID: 26020488 [TBL] [Abstract][Full Text] [Related]
36. Distinct sets of genetic alterations in melanoma. Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983 [TBL] [Abstract][Full Text] [Related]
37. An integrated multi-molecular sensor for simultaneous BRAF Dey S; Koo KM; Wang Z; Sina AAI; Wuethrich A; Trau M Lab Chip; 2019 Feb; 19(5):738-748. PubMed ID: 30624446 [TBL] [Abstract][Full Text] [Related]
38. Detection of BRAFV600E Mutation in Melanoma Patients by Digital PCR of Circulating DNA. Burjanivova T; Malicherova B; Grendar M; Minarikova E; Dusenka R; Vanova B; Bobrovska M; Pecova T; Homola I; Lasabova Z; Plank L Genet Test Mol Biomarkers; 2019 Apr; 23(4):241-245. PubMed ID: 30676087 [TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemistry using clone VE1 is an economic, specific and sensitive method for detecting the presence of BRAFV600E mutations in melanoma]. Etienne M; Oca F; Prunier-Mirebeau D; Croué A; Martin L Ann Dermatol Venereol; 2018 Mar; 145(3):159-165. PubMed ID: 29221650 [TBL] [Abstract][Full Text] [Related]
40. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Loria R; Bon G; Perotti V; Gallo E; Bersani I; Baldassari P; Porru M; Leonetti C; Di Carlo S; Visca P; Brizzi MF; Anichini A; Mortarini R; Falcioni R Oncotarget; 2015 Feb; 6(5):2779-93. PubMed ID: 25576923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]